Literature DB >> 6337739

The feedback regulation of angiotensinogen production by components of the renin-angiotensin system.

H C Herrmann, V J Dzau.   

Abstract

The in vivo generation of angiotensin appears to be dependent on both plasma renin and angiotensinogen concentrations. Much less is known about the control of hepatic angiotensinogen synthesis and release, as compared to that of renin. In this study, we examined the feedback regulation of angiotensinogen synthesis and release by various components of the renin-angiotensin system, using an in vitro rat liver slice system. Livers were removed for study from rats which were subjected to various systemic infusions or physiological perturbations. Infusion of angiotensin II has been reported to increase angiotensinogen release rate. However, infusion of angiotensin I (with simultaneous suppression of plasma renin by antirenin antibody infusion and angiotensin II production by captopril administration) had no effect on the angiotensinogen release rate. Direct infusion of renin in rats treated with captopril resulted in further suppression of the angiotensinogen release rate, compared with those given captopril alone. We postulate that renin (or des-angiotensin I-angiotensinogen) inhibits the angiotensinogen release rate, whereas angiotensin II stimulates it. Angiotensin I has no effect on angiotensinogen release rate. This hypothesis was evaluated further in rats with various physiological states. Indeed, when conditions were such that the renin-angiotensin system was completely suppressed, such as binephrectomy and antirenin antibody infusion, angiotensinogen release rate was markedly stimulated. When angiotensin II production was prevented by captopril treatment, angiotensinogen release rate declined. This appeared to be the case for all states of sodium balance. Thus, angiotensinogen release rate is subject to a complex feedback control by other components of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337739     DOI: 10.1161/01.res.52.3.328

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Central angiotensin II has catabolic action at white and brown adipose tissue.

Authors:  Annette D de Kloet; Eric G Krause; Karen A Scott; Michelle T Foster; James P Herman; Randall R Sakai; Randy J Seeley; Stephen C Woods
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-23       Impact factor: 4.310

Review 2.  Urinary markers of intrarenal renin-angiotensin system activity in vivo.

Authors:  Lodi C W Roksnoer; Koen Verdonk; Anton H van den Meiracker; Ewout J Hoorn; Robert Zietse; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

3.  Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.

Authors:  D J Campbell; J F Habener
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.

Authors:  Congqing Wu; Yinchuan Xu; Hong Lu; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Craig W Vander Kooi; Lisa A Cassis; Jian-an Wang; Alan Daugherty
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

5.  Effects of glucocorticoids and antiglucocorticoid on angiotensinogen production by hepatoma cells in culture.

Authors:  E Coezy; J Bouhnik; E Clauser; F Pinet; M Philippe; J Menard; P Corvol
Journal:  In Vitro       Date:  1984-07

6.  Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla.

Authors:  J R Ingelfinger; R E Pratt; K Ellison; V J Dzau
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

7.  Androgen regulation of rat renal angiotensinogen messenger RNA expression.

Authors:  K E Ellison; J R Ingelfinger; M Pivor; V J Dzau
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.

Authors:  H Schunkert; J R Ingelfinger; A T Hirsch; S S Tang; S E Litwin; C E Talsness; V J Dzau
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 9.  Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.

Authors:  Hiroyuki Kobori; Maki Urushihara
Journal:  Pflugers Arch       Date:  2012-08-24       Impact factor: 3.657

Review 10.  Angiotensin II blockade and renal protection.

Authors:  Hiroyuki Kobori; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.